RecruitingPhase 1NCT05147675
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Osteoarthritis
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Enrollment
92 participants
Start Date
Dec 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells delivered intravenously and intraarticularly for the treatment of Osteoarthritis.
Eligibility
Inclusion Criteria2
- Diagnosis of Osteoarthritis
- Understanding and willingness to sign a written informed consent document
Exclusion Criteria10
- Active infection
- Active cancer
- Chronic multisystem organ failure
- Pregnancy
- Clinically significant Abnormalities on pre-treatment laboratory evaluation
- Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
- Continued drug abuse
- Pre-menopausal women not using contraception
- Previous organ transplant
- Hypersensitivity to sulfur
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALAlloRx
cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05147675
Related Trials
Assessing Central Aspects of Pain
NCT065182781 location
Dose Response of Exercise for Arthritis Management
NCT068806531 location
Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.
NCT069028051 location
Arthrosemid vs. Steroid for the Management Knee Osteoarthritis
NCT074895211 location
Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis
NCT074048911 location